Immuron Ltd SEC filings IMRN
Immuron Ltd has 427 filings in SEC EDGAR's recent list, going back to Dec 21, 2016. Its latest annual report, Form 20-F, was filed on Sep 24, 2026 for the period ended Jun 30, 2026. The most recent current report (Form 6-K) was filed on Oct 28, 2026. The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jul 19, 2024 | — |
| CORRESP | Letter to the SEC | Jul 18, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 8, 2024 | — |
| 25-NSE | Delisting notice | Jun 10, 2022 | — |
| EFFECT | Filing | Apr 17, 2019 | — |
| CORRESP | Letter to the SEC | Apr 15, 2019 | — |
| UPLOAD | Letter from the SEC | Apr 11, 2019 | — |
| RW | Filing | Apr 8, 2019 | — |
| EFFECT | Filing | Feb 11, 2019 | — |
| NT 20-F | Filing | Oct 31, 2017 | Jun 30, 2017 |
| UPLOAD | Letter from the SEC | Jul 11, 2017 | — |
| UPLOAD | Letter from the SEC | Jul 11, 2017 | — |
| UPLOAD | Letter from the SEC | Jul 11, 2017 | — |
| CT ORDER | Filing | Jun 12, 2017 | — |
| EFFECT | Filing | Jun 8, 2017 | — |
| CERTNAS | Auto-generated paper document | Jun 8, 2017 | — |
| CORRESP | Letter to the SEC | Jun 6, 2017 | — |
| CORRESP | Letter to the SEC | Jun 6, 2017 | — |
| CORRESP | Letter to the SEC | Jun 1, 2017 | — |
| CORRESP | Letter to the SEC | Jun 1, 2017 | — |
| CORRESP | Letter to the SEC | May 26, 2017 | — |
| CORRESP | Letter to the SEC | May 26, 2017 | — |
| CORRESP | Letter to the SEC | May 26, 2017 | — |
| CORRESP | Letter to the SEC | May 25, 2017 | — |
| CORRESP | Letter to the SEC | May 25, 2017 | — |
| 8-A12B | Filing | May 25, 2017 | — |
| CORRESP | Letter to the SEC | May 25, 2017 | — |
| CORRESP | Letter to the SEC | May 25, 2017 | — |
| CORRESP | Letter to the SEC | May 25, 2017 | — |
| CORRESP | Letter to the SEC | May 24, 2017 | — |
| CORRESP | Letter to the SEC | May 22, 2017 | — |
| UPLOAD | Letter from the SEC | May 19, 2017 | — |
| CORRESP | Letter to the SEC | May 11, 2017 | — |
| UPLOAD | Letter from the SEC | May 10, 2017 | — |
| CORRESP | Letter to the SEC | May 8, 2017 | — |
| UPLOAD | Letter from the SEC | Apr 26, 2017 | — |
| CORRESP | Letter to the SEC | Apr 7, 2017 | — |
| UPLOAD | Letter from the SEC | Feb 23, 2017 | — |
| CORRESP | Letter to the SEC | Feb 8, 2017 | — |
| UPLOAD | Letter from the SEC | Jan 18, 2017 | — |
Showing 40 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IMRN (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- Australia
- Headquarters
- Carlton, Victoria, Australia
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1660046
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.